Observational studyPloS one2020

PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancer.

L Mineur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.